September 23, 2021
Therapy using dual immune system cells effectively controls neuroblastoma
Hongwei Du, PhD, Gianpietro Dotti, MD, and colleagues developed a new therapeutic approach that has shown successful results in lab models.
Tag: CAR-T
June 28, 2021
BioWorld: Other news to note
April 23, 2021
Scientists make donation when cancer hits close to home
Barbara Savoldo, MD, PhD, and Gianpietro Dotti, MD, have established a fund to develop a CAR-T therapy for glioblastoma in honor of Savoldo's sister, Sonia.
March 4, 2021
Engineered safety switch curbs severe side effects of CAR-T immunotherapy
As part of a study led by Matthew Foster, MD, the advance was seen in a patient enrolled in a clinical trial using CAR-T to treat refractory acute B-cell leukemia.
January 25, 2021
European Medicines Agency awards priority designation for Hodgkin lymphoma CAR-T therapy
The European Medicines Agency granted priority medicines designation to Tessa Therapeutics’ CD30 targeted CAR-T therapy for patients with relapsed or refractory Hodgkin lymphoma.
January 6, 2021
Pharmacy Times: Study Suggests Way to Boost Immunotherapy Against Breast Cancer, Other Solid Tumors
January 4, 2021
Fierce Biotech: Research Putting the ‘STING’ on CAR-T cells to turn them against breast cancer and other solid tumors
January 4, 2021
Drug Target Review: Activating STING enhances CAR T-cell activity in solid tumours, shows study
December 31, 2020
United Press International: Study: Modified immunotherapy may work in advanced breast cancer
December 31, 2020
Study points the way to boosting immunotherapy effectiveness against breast cancer and other solid tumors
CAR-T therapy has proven effective for some blood cancers. New research by Jonathan S. Serody, MD, and colleagues suggests ways to use it effectively to attack solid tumors.